Startup

Abionic

Description

Abionic, based in the Biopole life sciences campus in Lausanne, Switzerland, is a pioneering company developing in vitro diagnostic solutions using proprietary nanofluidic technology. Their innovative abioSCOPE(r) platform enables healthcare professionals to conduct ultra-rapid panel tests at the point of care, analyzing up to 14 parameters simultaneously with just one drop of blood in about 5 minutes. With a primary focus on fighting sepsis, Abionic is an active member of the Global Sepsis Alliance, striving to save lives by providing cost-effective, laboratory-quality results with easy handling for non-specialists.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.